IP Library Granted Patent US 8,771,982
Granted Patent B2
US 8,771,982 · App. 10/554,295 · Granted Jul 8, 2014

Chimeric molecule and nucleic acid encoding same

Inventors: Christopher M. Counter (Durham, NC); Blaine N. Armbruster (Durham, NC)
Assignee: Duke University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,771,982
App. No.
10/554,295
Granted
Jul 8, 2014
Kind
B2
Abstract

The present invention relates, in general, to telomeres, and, in particular, to a method or effecting telomere elongation in mammalian cells. The invention further relates to a protein suitable for use in such a method and to nucleic acid sequences encoding same.

Claims (14)

1. An isolated nucleic acid sequence encoding a chimeric molecule comprising a polypeptide having telomerase catalytic activity fused to a telomere binding polypeptide wherein said nucleic acid sequence comprises the nucleotide sequence set forth in SEQ ID NO:1.

2. An expression construct comprising said nucleic acid sequence according to claim 1 operably linked to a promoter.

3. A vector comprising the nucleic acid sequence according to claim 1 .

4. The vector according to claim 3 wherein said vector is a viral vector.

5. The vector according to claim 4 wherein said viral vector is a retroviral vector, adeno-associated viral vector, lentiviral vector or adenoviral vector.

6. A liposome comprising the nucleic acid sequence according to claim 1 .

7. A composition comprising the nucleic acid sequence according to claim 1 encapsulated in a polymer.

8. An isolated cell comprising the nucleic acid sequence according to claim 1 .

9. The cell according to claim 8 wherein said cell is a stem or progenitor cell.

10. The cell according to claim 8 wherein said cell is an epithelial cell or a fibroblast.

11. The cell according to claim 8 wherein said cell is a muscle cell, nervous system cell, or keratinocyte.

12. The cell according to claim 8 wherein said cell is a human cell.

13. The cell according to claim 8 wherein said cell is immortal.

14. A method of producing a protein comprising culturing said cell according to claim 8 under conditions such that said nucleic acid sequence is expressed and said molecule is thereby produced.

Assignments (2)
CONFIRMATORY LICENSE Recorded Feb 10, 2020
From: DUKE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 051867/0717 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2006
From: COUNTER, CHRISTOPHER M.; ARMBRUSTER, BLAINE N.
To: DUKE UNIVERSITY
Reel/Frame 018185/0668 →
Continuity (2)
Provisional Application 60466427 · Apr 30, 2003
Related Publication 20070020722A1 · Jan 25, 2007